Ford Motor Q1 Results Beat Street View

Ford Motor Co. (F) Wednesday reported first-quarter profit of $3.3 billion or $0.81 per share, compared to last year's loss of $2.0 billion or $0.50 per share.

Excluding items, adjusted earnings for the quarter were $0.89 per share, compared to a loss of $0.23 per share. On average, 16 analysts polled by Thomson Reuters expected the company to report an earnings of $0.21 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues for the quarter gained 6% to $36.2 billion from $34.3 billion in the same period last year. Analysts expected revenue of $32.23 billion for the quarter.

Looking forward, the company now assumes that it will lose 10% of planned second-half 2021 production. Ford now expects to lose about 1.1 million units of production this year to the semiconductor shortage.

The company now anticipates full-year 2021 adjusted EBIT to be between $5.5 billion and $6.5 billion, including an adverse effect of about $2.5 billion from the semiconductor issue.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT